The main risk is not whether Vicor solves a real problem; it likely does. The real risk is whether it captures enough of that value before capacity limits, customer concentration, larger analog rivals and valuation compression absorb the upside. If recurring
royalties fail to scale, Gen 2 qualifications slip, or second-
fab timing stretches, strong revenue growth may still produce only middling shareholder returns.